Cover Image
市場調查報告書

印尼的感染疾病IVD市場

Indonesian Infectious Disease IVD Market

出版商 Frost & Sullivan 商品編碼 304810
出版日期 內容資訊 英文 71 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
印尼的感染疾病IVD市場 Indonesian Infectious Disease IVD Market
出版日期: 2014年05月26日 內容資訊: 英文 71 Pages
簡介

印尼的感染疾病IVD(體外診斷)市場對參與企業的各種層級來說顯示著多樣的成長可能性。國內企業一方面從低階市場得到成長的氣勢,外國的主要製造商獨佔著高階市場。

本報告提供印尼的感染疾病IVD(體外診斷)市場相關分析、各市場區隔的收益預測、促進要素與阻礙要素、技術趨勢、競爭要素及策略的分析。

本報告提供以下問題的答案。

  • 印尼的感染疾病IVD市場現狀為何?其持續期間為?
  • 主要的市場區隔為何?還有重要的趨勢為何?
  • 主要的推動市場要素是什麼?還有需要解決的障礙為何?
  • 隨時間流逝市場結構如何變化?
  • 主要打入市場企業為何?立場為何?
  • 印尼的感染疾病IVD市場未來將如何?市場參與企業為成功應該做什麼?

第1章 摘要整理

第2章 市場概要

第3章 競爭劇本

  • PEST分析
  • 新的市場機會
  • 市場佔有率
  • 市場佔有率分析
  • 競爭環境
  • 多國籍vs.本地企業
  • 合併、收購、聯盟的評估

第4章 預測與趨勢:感染疾病IVD整體市場

  • 檢測
  • 預測的前提條件
  • 收益預測
  • 收益預測的議論
  • 收益比預測:各市場區隔
  • 市場區隔的生命週期分析
  • 主要市場區隔趨勢

第5章 免疫化學檢查市場區隔分析

  • 市場區隔概要
  • 檢測
  • 收益預測
  • 收益預測的議論
  • 競爭環境

第6章 微生物學市場區隔分析

第7章 分子診斷市場區隔分析

第8章 結論、策略性建議

第9章 附錄

第10章 主要企業

  • Roche
  • Abbott
  • Bio-Merieux
目錄
Product Code: P7F9-01-00-00-00

Mapping the Market for Investment, Best Practices, and Growth Potential

The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and provides an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies. The infectious disease IVD market in Indonesia can be divided into segments such as microbiology testing, immunochemistry testing, and molecular diagnostics testing. The study covers the period 2012 to 2017.

Key Questions This Study Will Answer

  • What is the current scenario of Indonesian infectious disease IVD market, and how far will it go?
  • Which are the major market segments, and what are the important trends?
  • What are the key factors driving the market and barriers that need to be resolved?
  • How will the structure of the market change over time?
  • Which are the key market participants involved, and where do they stand?
  • What is the future of the infectious disease IVD market in Indonesia, and what should market participants do to succeed?

Table of Contents

1. EXECUTIVE SUMMARY

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Key Questions This Study Will Answer
  • 4. Measurements
  • 5. CEO's Perspective
  • 6. Key Companies to Watch
  • 7. Game-changing Strategies
  • 8. Three Big Predictions

2. MARKET OVERVIEW

  • 1. Market Definitions
  • 2. Research Scope and Objectives
  • 3. Indonesia Overview
  • 4. Market Background
  • 5. Market Background (continued)
  • 6. Market Segmentation
  • 7. Reimbursement Overview

3. COMPETITIVE PLAYBOOK

  • 1. PEST Analysis
  • 2. New Market Opportunities
  • 3. New Market Opportunities (continued)
  • 4. Market Share
  • 5. Market Share Analysis
  • 6. Competitive Environment
  • 7. Multinational Versus Local Participants
  • 8. Merger, Acquisition, and Partnership Assessment

4. FORECAST AND TRENDS-TOTAL INFECTIOUS DISEASE IVD MARKET

  • 1. Measurements
  • 2. Forecast Assumptions
  • 3. Forecast Assumptions (continued)
  • 4. Revenue Forecast
  • 5. Revenue Forecast Discussion
  • 6. Per cent Revenue Forecast by Segment
  • 7. Segment Life Cycle Analysis
  • 8. Key Segment Trends

5. IMMUNOCHEMISTRY TESTING SEGMENT BREAKDOWN

  • 1. Immunochemistry Segment Overview
  • 2. Measurements
  • 3. Revenue Forecast
  • 4. Revenue Forecast Discussion
  • 5. Competitive Environment

6. MICROBIOLOGY SEGMENT BREAKDOWN

  • 1. Microbiology Segment Overview
  • 2. Measurements
  • 3. Revenue Forecast
  • 4. Revenue Forecast Discussion
  • 5. Competitive Environment

7. MOLECULAR DIAGNOSTICS SEGMENT BREAKDOWN

  • 1. Molecular Diagnostics Segment Overview
  • 2. Measurements
  • 3. Revenue Forecast
  • 4. Revenue Forecast Discussion
  • 5. Competitive Environment

8. CONCLUSIONS AND STRATEGIC RECOMMENDATIONS

  • 1. Conclusions
  • 2. Strategic Recommendations
  • 3. Legal Disclaimer

9. APPENDIX

  • 1. Methodology
  • 2. Learn More-Next Steps
  • 3. Table of Acronyms Used
  • 4. Table of Acronyms Used (continued)

10. TOP COMPANIES

  • 1. Roche
  • 2. Abbott
  • 3. Bio-Merieux
Back to Top